The aim of the Journal is to advance the development of a hierarchical and functional integrative approach to the neurosciences with an emphasis on: (i) neuroimaging, (ii) comparative experimentation, and (iii) data driven modeling, including the theoretical and philosophical foundations of this approach.The scope of the Journal is broad, encompassing all aspects of brain function, including regulation of homeostatic and maintenance functions, and behaviors in health and disease.The Journal will promote and disseminate studies categorized under the following themes: * Theoretical methods and analytical techniques allowing integration in neuroscience (e.g., infinite dimensional nonlinear dynamical systems, theory of complexity, n-field theory, diffusion theory, category theory, graph theory); * Experimentally and mathematically integrated models of brain activity (e.g., volume transmission and deep brain stimulation, large-scale realistic cable networks of cortical and sub-cortical integration); * Functional integration of physiological control mechanisms with anatomical structure in the nervous system, central and peripheral (e.g., control and regulation in the cardio-vascular and respiratory systems, autonomic control); * Bio-engineering and experimental techniques allowing integration in neuroscience (e.g., Human-machine interface technology, brain-based devices, optical recording, multi-electrode arrays, neuroimaging); * Experimentally-based neuropsychological and neurophilosophical models (e.g., semantic ambiguity, anticipatory behavior, free will, epistemological limitations in understanding consciousness); * Applications of integration to neural pathologies and neural control physiology (e.g., brain diseases, plasticity and rehabilitation, interface between functional genomics and psychiatric illnesses).The following types of experimental and theoretical papers are suitable for the Journal: * Rapid communications and forum style commentary articles (approx. 16 pages; 20 citations) * Original articles containing research reports (approx. 40 pages; 60 citations) * Topical reviews containing critical survey of the literature (approx. 40 pages; 120 citations) * Book reviews.
The Journal of Intellectual Disability Research is devoted exclusively to the scientific study of intellectual disability and publishes papers reporting original observations in this field. The subject matter is broad and includes, but is not restricted to, findings from biological, educational, genetic, medical, psychiatric, psychological and sociological studies, and ethical, philosophical, and legal contributions that increase knowledge on the treatment and prevention of intellectual disability and of associated impairments and disabilities, and/or inform public policy and practice. Expert reviews on themes in which recent research has produced notable advances will be included. Such reviews will normally be by invitation. Anyone expert in his/her particular field wishing to submit an uninvited review is advised to seek prior guidance from the Editor. The Journal also includes brief reports, occasional letters, and an 'Hypothesis' section. All papers are assessed by expert referees.
The Journal of Mathematical Neuroscience (JMN) is a peer-reviewed open access journal published under the brand SpringerOpen. It is publishing research articles on the mathematical modeling and analysis of all areas of neuroscience, i.e., the study of the nervous system and its dysfunctions.The focus is on using mathematics as the primary tool for elucidating the fundamental mechanisms responsible for experimentally observed behaviours in neuroscience at all relevant scales, from the molecular world to that of cognition.
The Journal of Molecular Neuroscience is committed to the rapid publication of original findings that increase our understanding of the molecular structure, function, and development of the nervous system. The criteria for acceptance of manuscripts will be scientific excellence, originality, and relevance to the field of molecular neuroscience. Manuscripts with clinical relevance are especially encouraged since the journal seeks to provide a means for accelerating the progression of basic research findings toward clinical utilization. All experiments described in the Journal of Molecular Neuroscience that involve the use of animal or human subjects must have been approved by the appropriate institutional review committee and conform to accepted ethical standards. Five-year Impact Factor: (2008) 2.373
Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.
The goal of the Journal is as a forum for the interdisciplinary field of neural engineering where neuroscientists, neurobiologists and engineers can publish their work in one periodical that bridges the gap between neuroscience and engineering. The Journal publishes articles in the field of neural engineering at the molecular, cellular and systems levels.The scope of the Journal encompasses experimental, computational, theoretical, clinical and applied aspects of brain-machine (computer) interface neural interfacing neurotechnology neuroelectronics neuromodulation neural prostheses neural control neuro-rehabilitation neurorobotics optical neural engineering neural circuits: artificial & biological neuromorphic engineering neural tissue regeneration neural signal processing theoretical and computational neuroscience systems neuroscience translational neuroscience.
The investigation of basic mechanisms involved in the pathogenesis of neurological and psychiatric disorders has deepened our knowledge of these disorders and their treatment. The Journal of Neural Transmission establishes an interface between basic sciences and clinical neurology and psychiatry and acts as a platform for translational research publications in neurosciences and associated clinical fields, thus bridging the gap between basic knowledge and clinical application.The journal is published monthly in three sections: 'Translational Neuroscience', 'Neurology and preclinical neurological studies' and 'Psychiatry and preclinical psychiatric studies'.
The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan literally dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
The Journal of NeuroVirology (JNV) provides a unique platform for the publication of high-quality basic science and clinical studies on the molecular biology and pathogenesis of viral infections of the nervous system, and for reporting on the development of novel therapeutic strategies using neurotropic viral vectors. The Journal also emphasizes publication of non-viral infections that affect the central nervous system. The Journal publishes original research articles, reviews, case reports, coverage of various scientific meetings, along with supplements and special issues on selected subjects.The Journal is currently accepting submissions of original work from the following basic and clinical research areas: Aging & Neurodegeneration, Apoptosis, CNS Signal Transduction, Emerging CNS Infections, Molecular Virology, Neural-Immune Interaction, Novel Diagnostics, Novel Therapeutics, Stem Cell Biology, Transmissable Encephalopathies/Prion, Vaccine Development, Viral Genomics, Viral Neurooncology, Viral Neurochemi
Journal of Neurochemistry continues to be a leading source for research into all aspects of neuroscience, with a particular focus on molecular and cellular aspects of the nervous system, the pathogenesis of neurological disorders and the development of disease specific biomarkers. JNC is devoted to the prompt publication of original findings of the highest scientific priority and value.
Journal of Neurodevelopmental Disorders is an open access, peer-reviewed journal that integrates current, cutting-edge research across a number of disciplines, including neurobiology, genetics, cognitive neuroscience and psychology. The primary focus is on the pathogenesis of neurodevelopmental disorders including autism, Fragile X Syndrome, tuberous sclerosis, Turner Syndrome, 22q Deletion Syndrome, Prader-Willi Angelman Syndrome, Williams Syndrome, Lysosomal Storage Diseases, dyslexia, specific language impairment and Fetal Alcohol Syndrome.
The Journal of Neuroendocrinology provides the principal international focus for the newest ideas in classical neuroendocrinology and its expanding interface with the regulation of behavioural, cognitive, developmental, degenerative and metabolic processes. Through the rapid publication of original manuscripts and provocative review articles, it provides essential reading for basic scientists and clinicians researching in this rapidly expanding field.
Under new editorship from 2008, Journal of Neurogenetics continues to publish papers involving the genetics of behavior, neural function or development, interpreted in the broadest sense. The Journal may be particularly appropriate for papers on behavioral, biochemical, or cellular aspects of neural function, plasticity, aging or disease. In addition to analyses in the traditional genetic-model organisms, C. elegans, Drosophila, mouse and the zebrafish, the Journal encourages submission of neurogenetic investigations performed in organisms not easily amenable to experimental genetics. Such investigations might, for instance, describe behavioral differences deriving from genetic variation within a species, or report human disease studies that provide exceptional insights into biological mechanisms. Manuscripts simply documenting the correlation of specific human SNPs with behavioral traits or neurological disorders are outside of the Journal's current Scope and will not be considered. In addition to Original Articles, the Journal will also publish Short Communications, and Hypotheses, as well as Invited Commentaries and Reviews. Meeting Reports or groups of Abstracts associated with Neurogeneticsconferences will also appear on a regular basis.In an attempt to energize the Journal, the new editorship:a) Has revised the presentation and has provided online access to the Journal; andb) Makes the following commitments to prospective authors: *To provide a fair and constructive peer review of manuscripts submitted.*To ensure that accepted manuscripts appear in electronic databases within six weeks of final acceptance.*To provide rapid editorial review of papers previously reviewed by other journals.*To allow authors maximal latitude in discussing the wide implications of their work and, when duly qualified, encourage discussions that question current models.*To improve representation of research from countries outside Europe and North America.
The Journal of Neuroimmune Pharmacology (JNIP) is the peer-reviewed journal of the Society on NeuroImmune Pharmacology. JNIP interfaces the disciplines of immunology, pharmacology and experimental neuroscience by acting as a platform for research discoveries into the pathogenesis and pharmacology of nervous system disorders affecting the immune system and vice versa. Original interdisciplinary scientific contributions, concise 'opinion,' and broad reviews are welcome. Research areas reporting in JNIP include receptor cell signaling, the pathobiology, cognitive neuroscience, psychopharmacology and immunity of drugs of abuse, neurodegenerative disorders, neurovirology, neuroimmunology, and neuropharmacology. Manuscripts must include original research linked to the immunology and pharmacology of human neurologic and neuropsychiatric disorders including substance abuse, depression, psychosis, Alzheimer's and Parkinson's disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, HIV-associated neurocognitive diso
The Journal of Neuroimmunology affords a forum for the publication of works applying immunologic methodology to the furtherance of the neurological sciences. Studies on all branches of the neurosciences, particularly fundamental and applied neurobiology, neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays), are considered for publication.Works pertaining to multiple sclerosis, AIDS, amyotrophic lateral sclerosis, Guillain Barré Syndrome, myasthenia gravis, and brain tumors form a major focus. The scope of the Journal is broad, covering both research and clinical problems of neuroscientific interest.A major aim of the Journal is to encourage the development of immunologic approaches to analyse in further depth the interactions and specific properties of nervous tissue elements during development and disease.
Journal of Neuroinflammation is ready to receive manuscripts on all aspects of innate immunological responses of the central nervous system.
The Journal of Neurolinguistics is an international forum for the integration of the neurosciences and language sciences. JNL provides for rapid publication of novel, peer-reviewed research into the interaction between language, communication and brain processes. The focus is on rigorous studies of an empirical or theoretical nature and which make an original contribution to our knowledge about the involvement of the nervous system in communication and its breakdowns. Contributions from neurology, communication disorders, linguistics, neuropsychology and cognitive science in general are welcome. Published articles will typically address issues relating some aspect of language or speech function to its neurological substrates with clear theoretical import. Interdisciplinary work on any aspect of the biological foundations of language and its disorders resulting from brain damage is encouraged. Studies of normal subjects, with clear reference to brain functions, are appropriate. Group-studies on well defined samples and case studies with well documented lesion or nervous system dysfunction are acceptable. The journal is open to empirical reports and review articles. Special issues on aspects of the relation between language and the structure and function of the nervous system are also welcome.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com